Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhangjiagang Glory Biomaterial is a prominent industrial biotechnology firm based in China, focused on the large-scale production of bio-based 1,3-propanediol (PDO). The company employs proprietary microbial fermentation processes to convert renewable corn-derived glucose into high-purity chemical intermediates. These products are essential for manufacturing sustainable Polytrimethylene Terephthalate (PTT) polymers used in the textile and carpet industries. Additionally, their bio-PDO is utilized as a high-performance, eco-friendly ingredient in cosmetics, personal care products, and pharmaceutical formulations as a solvent or humectant. By providing bio-sourced alternatives to petrochemicals, the company supports global initiatives for carbon reduction and sustainable manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhangjiagang Glory Biomaterial.